Patent
   D434846
Priority
Jul 07 1999
Filed
Jul 07 1999
Issued
Dec 05 2000
Expiry
Dec 05 2014
Assg.orig
Entity
unknown
18
19
n/a
The ornamental design for a tablet, as shown and described.

FIG. 1 is a top plan view of a tablet showing our new design;

FIG. 2 is a bottom plan view thereof;

FIG. 3 is a front elevational view thereof;

FIG. 4 is a rear elevational view thereof;

FIG. 5 is a left side elevational view thereof;

FIG. 6 is a right side elevational view thereof;

FIG. 7 is a top perspective view thereof, on an enlarged scale; and,

FIG. 8 is a bottom perspective view thereof, on an enlarged scale.

Katdare, Ashok V., Chen, Tzyy-Show H., Nyairo, Thomas G.

Patent Priority Assignee Title
D515202, Jul 19 2004 Merck Sharp & Dohme Corp Tablet
D670956, Mar 16 2012 E MISHAN & SONS, INC Pet treat baking machine
D735315, Jun 25 2012 Amgen Inc Pharmaceutical tablet
D744635, Jun 26 2014 Access Business Group International LLC Dietary supplement
D754840, Feb 03 2012 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D754841, Feb 03 2012 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D755949, Jul 30 2013 RB HEALTH US LLC Tablet
D778428, Feb 03 2012 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D785277, Feb 18 2016 MODORAL BRANDS INC Lozenge
D795525, Mar 16 2016 Intercontinental Great Brands LLC Confection
D813372, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D821682, Mar 16 2016 Intercontinental Great Brands LLC Confection
D835257, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835258, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D858741, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D906513, Mar 19 2019 Novo Nordisk A S Pill
D907760, Jan 20 2017 SOCIÉTÉ DES PRODUITS NESTLÉ S A Orally ingestible tablet
D947358, Mar 19 2019 Novo Nordisk A/S Pill
Patent Priority Assignee Title
2687367,
4693886, Apr 22 1985 ALZA Corporation Osmotic device with inert core
4851228, Jun 20 1984 MERCK & CO , INC , A CORP OF NJ Multiparticulate controlled porosity osmotic
5424074, Jun 20 1989 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition for potassium supplementation
5427798, Aug 14 1992 SMITHKLINE BEECHAM CORPORATION, A PENNSYLVANIA CORPORATION Controlled sustained release tablets containing bupropion
5512299, Mar 30 1992 ALZA Corporation Method of treating oral inflammatory disease
5770225, Apr 28 1989 McNeil-PPC, Inc. Process of preparing a subcoated simulated capsule-like medicament
216307,
D258091, Aug 31 1978 Marion Laboratories, Inc. Pharmaceutical tablet
D301764, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D302051, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D304626, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D316914, Aug 01 1989 MERRELL DOW PHARMACEUTICALS LTD Tablet
D359554, Dec 02 1991 The Procter & Gamble Company Tablet
D375157, Dec 22 1992 Merck Sharp & Dohme Corp Tablet
D379223, Sep 13 1995 Merck Sharp & Dohme Corp Pharmaceutical tablet
D380825, Oct 31 1994 Merck Sharp & Dohme Corp Pharmaceutical tablet
D400672, Mar 21 1996 Merck Sharp & Dohme Corp Pharmaceutical tablet
56478,
///////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jul 07 1999Merck & Co., Inc.(assignment on the face of the patent)
Sep 08 1999KATDARE, ASHOK V MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0107530411 pdf
Sep 10 1999CHEN, TZYY-SHOW H MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0107530417 pdf
Sep 10 1999NYAIRO, THOMAS G MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0107530417 pdf
Nov 02 2009MERCK & CO , INC Merck Sharp & Dohme CorpCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0238700001 pdf
Apr 26 2012Merck Sharp & Dohme CorpSchering CorporationMERGER SEE DOCUMENT FOR DETAILS 0288500515 pdf
May 02 2012Schering CorporationMerck Sharp & Dohme CorpCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0288660511 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule